Literature DB >> 25620393

Retraction statement: ‘Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c’ by Xianqing Ye, Fei Jiang, Yuan Li, Juan Mu, Lu Si, Xingxing Wang, Shilong Ning and Zhong L.

.   

Abstract

Entities:  

Year:  2015        PMID: 25620393      PMCID: PMC4317769          DOI: 10.1111/cas.12579

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


× No keyword cloud information.
The above article in Cancer Science (doi: 10.1111/cas.12426), published online on 20 May 2014 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the authors, the journal Editor in Chief, Yusuke Nakamura, and Wiley Publishing Asia Pty Ltd. The retraction has been agreed as Panels C, GLA 5, GLA 10 and GLA 20 shown in Figure 2 (Migration assay) all appear to have been taken from the same image, while Panels 1:Con, 2:GLA, 3:GLA + Anti-con and 4:GLA + Anti-miR-200c shown in Figure 7 (Migration assay) also appear to have been taken from the same image.
  1 in total

1.  Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.

Authors:  Xianqing Ye; Fei Jiang; Yuan Li; Juan Mu; Lu Si; Xingxing Wang; Shilong Ning; Zhong Li
Journal:  Cancer Sci       Date:  2014-05-21       Impact factor: 6.716

  1 in total
  1 in total

1.  Effects of glabridin combined with 5-fluorouracil on the proliferation and apoptosis of gastric cancer cells.

Authors:  Lei Zhang; Hongmei Chen; Mingfei Wang; Xiaojing Song; Fanghui Ding; Jun Zhu; Xun Li
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.